Royalty Pharma hires former Morgan Stanley analyst as VP

Marshall Urist appointed VP research and investment

NEW YORK — Royalty Pharma has hired Marshall Urist as VP research and investments, the company said Friday.

Royalty, which invests in royalty interests in drugs, hired Urist from Morgan Stanley, where he worked most recently as executive director and the senior biotechnology analyst.

"We are excited to have Marshall join our team," Royalty founder and CEO Pablo Legorreta said. "He has had a distinguished career on Wall Street, and this experience, coupled with his deep analytical skills, make him an excellent addition to Royalty Pharma."

 

Login or Register to post a comment.